A fierce legal showdown is unfolding over the $2.8 billion antitrust settlement with Blue Cross Blue Shield, with law firms racing against the clock as hospitals and healthcare providers decide whether to join the deal or take separate legal action.
At the heart of the conflict is a dispute between Whatley Kallas, the plaintiffs’ firm that helped broker the settlement, and rival firms vying to represent hospitals opting out of the deal. The stakes are high—potentially millions in legal fees for firms involved in related past litigation against the health insurer.
Whatley Kallas has asked a federal judge to bar Zuckerman Spaeder and Polsinelli from seeking to represent any hospitals that choose to sue Blue Cross independently. The firm argued that, as class counsel, it must ensure that opt-out decisions are made with unbiased legal counsel, free of conflicts.
The fight stems from prior cases where Blue Cross faced accusations of overcharging consumers and under-reimbursing providers. Zuckerman Spaeder had represented a class of insurance subscribers in a $2.7 billion settlement in 2020, which was upheld by the U.S. Supreme Court. Whatley Kallas claims this prior work creates a conflict of interest for Zuckerman in representing opt-out hospitals.
Zuckerman denied the allegations, warning that disqualifying the firm could set a dangerous precedent, preventing a host of qualified law firms from advising prospective opt-outs.
Meanwhile, Polsinelli faces similar accusations from Whatley Kallas based on previous work for Blue Cross. Boies Schiller Flexner, another major player from the earlier case, has also stepped into the fray, asserting its right to represent a healthcare client already suing Blue Cross in Michigan.
As hospitals weigh their options, the deadline for opting out of the settlement is fast approaching, set for March 4. With millions of dollars in legal fees hanging in the balance, the battle between these firms will continue to unfold in the courts.
